Sofosbuvir and ABT-450: Terminator of hepatitis C virus?

doi:10.3748/wjg.v19.i21.3199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8822)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

508

HTML

5339

Figures (1-1)

246

Tables (1-6)

219

Sum=6312

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1304

Download

1206

Sum=2510

Jun 7, 2013 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 7, 2013; 19(21): 3199-3206
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3199

Open in New Tab Full Size Figure Download Figure

Figure 1 Brief development history of the anti-hepatitis C virus agents. HCV: Hepatitis C virus; IFN-α: Interferon-α; SVR: Sustained virologic response; pegIFN-α: Peginterferon-α.

Citation: Zeng QL, Zhang JY, Zhang Z, Wang LF, Wang FS. Sofosbuvir and ABT-450: Terminator of hepatitis C virus? World J Gastroenterol 2013; 19(21): 3199-3206
URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3199.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3199